Feng He Fund Management Pte. Ltd. Legend Biotech Corp Transaction History

Feng He Fund Management Pte. Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $17.5 Million - $28.7 Million	-522,451 Reduced 52.36%	475,263 $26.1 Million
Q1 2022 May 05, 2022	BUY	$31.02 - $48.18 $13.6 Million - $21.1 Million	437,208 Added 78.0%	997,714 $36.3 Million
Q4 2021 Feb 14, 2022	SELL	$41.14 - $56.98 $176,902 - $245,014	-4,300 Reduced 0.76%	560,506 $26.1 Million
Q3 2021 Nov 03, 2021	BUY	$35.31 - $50.56 $1.37 Million - $1.96 Million	38,734 Added 7.36%	564,806 $28.6 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $3.95 Million - $6.29 Million	153,083 Added 41.04%	526,072 $21.6 Million
Q1 2021 Apr 21, 2021	BUY	$23.55 - $32.4 $2.45 Million - $3.37 Million	103,917 Added 38.62%	372,989 $10.8 Million
Q4 2020 Feb 03, 2021	BUY	$25.8 - $32.39 $6.94 Million - $8.72 Million	269,072 New	269,072 $7.58 Million

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Feng He Fund Management Pte. Ltd., based on Form 13F filings with the SEC.

Stay updated on Feng He Fund Management Pte. Ltd. with notifications on news.